ATE239485T1 - Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält - Google Patents

Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält

Info

Publication number
ATE239485T1
ATE239485T1 AT93100278T AT93100278T ATE239485T1 AT E239485 T1 ATE239485 T1 AT E239485T1 AT 93100278 T AT93100278 T AT 93100278T AT 93100278 T AT93100278 T AT 93100278T AT E239485 T1 ATE239485 T1 AT E239485T1
Authority
AT
Austria
Prior art keywords
acetylcysteine
polyvinyl alcohol
pharmaceutical preparation
ophthalmic pharmaceutical
preparation containing
Prior art date
Application number
AT93100278T
Other languages
English (en)
Inventor
Federico Stroppolo
Daniele Bonadeo
Francesco Tocchini
Annibale Gazzaniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE239485T1 publication Critical patent/ATE239485T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93100278T 1992-01-16 1993-01-11 Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält ATE239485T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920074A IT1258781B (it) 1992-01-16 1992-01-16 Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol

Publications (1)

Publication Number Publication Date
ATE239485T1 true ATE239485T1 (de) 2003-05-15

Family

ID=11361572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93100278T ATE239485T1 (de) 1992-01-16 1993-01-11 Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält

Country Status (9)

Country Link
US (2) US5510101A (de)
EP (1) EP0551848B1 (de)
JP (1) JP3443128B2 (de)
AT (1) ATE239485T1 (de)
AU (1) AU653091B2 (de)
CA (1) CA2087420C (de)
DE (1) DE69332939T2 (de)
ES (1) ES2197146T3 (de)
IT (1) IT1258781B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2350715A1 (en) * 1999-08-09 2001-04-12 Webb-Waring Institute For Biomedical Research A method for the treatment of ocular oxidative stress
CN1443064A (zh) * 2000-04-26 2003-09-17 俄勒冈健康科学大学 施用含硫醇化学保护化合物的方法
ES2254523T3 (es) * 2000-11-22 2006-06-16 Rxkinetix, Inc. Tratamiento de mucositis.
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
ITRM20010438A1 (it) * 2001-07-23 2003-01-23 Farmigea Spa Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
GB0123115D0 (en) * 2001-09-26 2001-11-14 Pharma Sol Int Ltd Saline solutions for clinical use
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
US20070077303A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
EP1965787B1 (de) * 2005-11-30 2013-04-10 Endo Pharmaceuticals Inc. Behandlung der Xerostomie mit einem schwefelhaltigen Antioxidant
DK3184526T3 (en) 2005-12-13 2019-01-14 Incyte Holdings Corp PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR
EP2740731B1 (de) 2007-06-13 2016-03-23 Incyte Holdings Corporation Kristalline Salze des Janus-Kinasehemmers (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-YL)-1H-pyrazol-1-YL)-3-cyclopentylpropanenitril
CL2009001884A1 (es) * 2008-10-02 2010-05-14 Incyte Holdings Corp Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
WO2010135621A1 (en) * 2009-05-22 2010-11-25 Incyte Corporation 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
ES2487542T3 (es) * 2009-05-22 2014-08-21 Incyte Corporation Derivados de N-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de cinasas Janus
WO2011028685A1 (en) * 2009-09-01 2011-03-10 Incyte Corporation Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
SMT201800137T1 (it) 2010-03-10 2018-07-17 Incyte Holdings Corp Derivati di piperidin-4-il azetidina come inibitori di jak1
PH12012502296B1 (en) 2010-05-21 2017-10-06 Incyte Holdings Corp Topical formulation for a jak inhibitor
ES2536415T3 (es) 2010-11-19 2015-05-25 Incyte Corporation Pirrolopiridinas y pirrolopirimidinas sustituidas heterocíclicas como inhibidores de JAK
SG190839A1 (en) 2010-11-19 2013-07-31 Incyte Corp Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
WO2012177606A1 (en) 2011-06-20 2012-12-27 Incyte Corporation Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
WO2013173720A1 (en) 2012-05-18 2013-11-21 Incyte Corporation Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
PE20151157A1 (es) 2012-11-15 2015-08-19 Incyte Corp Formas de dosificacion de ruxolitinib de liberacion sostenida
LT3489239T (lt) 2013-03-06 2022-03-10 Incyte Holdings Corporation Jak inhibitoriaus gamybos būdai ir tarpiniai junginiai
UA120499C2 (uk) 2013-08-07 2019-12-26 Інсайт Корпорейшн Лікування захворювань із застосуванням лікарських форм з уповільненим вивільненням для інгібітора jak1
SG11201608402WA (en) 2014-05-07 2016-11-29 Croma Pharma Ges M B H Aqueous ophthalmic solution and method for treating dry eye syndrome
WO2015184305A1 (en) 2014-05-30 2015-12-03 Incyte Corporation TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
ES2796361T3 (es) 2015-10-30 2020-11-26 Croma Pharma Gmbh Uso terapéutico de una solución oftálmica acuosa estéril
RU2018119674A (ru) 2015-10-30 2019-12-02 Крома-Фарма Гезелльшафт М.Б.Х. Применение в терапии стерильного водного офтальмологического раствора
US11484516B2 (en) 2017-03-29 2022-11-01 Azura Ophthalmics Ltd. Agents for increasing meibomian gland lipid secretion
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
WO2019113487A1 (en) 2017-12-08 2019-06-13 Incyte Corporation Low dose combination therapy for treatment of myeloproliferative neoplasms
IL276302B2 (en) 2018-01-30 2023-11-01 Incyte Corp Procedures for preparing [1-(3-fluoro-2-(trifluoromethyl(isonicotinyl}piperidine-4-one)
SMT202400306T1 (it) 2018-03-30 2024-09-16 Incyte Corp Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak.
US20220409526A1 (en) * 2019-11-08 2022-12-29 Retina Foundation Of The Southwest Compounds and implants for treating ocular disorders
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120949A (en) * 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4131651A (en) * 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
IT1249047B (it) * 1991-02-21 1995-02-11 Zambon Spa Composizione farmaceutica per il trattamento della cataratta
NZ242358A (en) * 1991-05-10 1994-03-25 Allergan Inc Use of thiol compounds to inhibit deposits on a contact lens

Also Published As

Publication number Publication date
CA2087420A1 (en) 1993-07-17
ITMI920074A0 (it) 1992-01-16
EP0551848B1 (de) 2003-05-07
JPH069383A (ja) 1994-01-18
ES2197146T3 (es) 2004-01-01
CA2087420C (en) 2004-04-20
DE69332939D1 (de) 2003-06-12
DE69332939T2 (de) 2004-04-01
IT1258781B (it) 1996-02-29
US5510101A (en) 1996-04-23
US5488069A (en) 1996-01-30
EP0551848A1 (de) 1993-07-21
AU653091B2 (en) 1994-09-15
AU3113693A (en) 1993-07-22
JP3443128B2 (ja) 2003-09-02
ITMI920074A1 (it) 1993-07-16

Similar Documents

Publication Publication Date Title
DE69332939D1 (de) Ophthalmische pharmazeutische Zubereitung die N-Acetylcystein und Polyvinylalkohol enthält
AU659444B2 (en) Intermediates for the manufacture of 6-fluoro-1, 4-dihydro-4-oxoquinoline carboxylic acids
DK153687D0 (da) Laegemiddel-adsorbater og deres fremstilling
OA09123A (fr) Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles.
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE69326539D1 (de) Zytotoxische arzneimittel therapie
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
EP0235589A3 (en) Use of quinolone and naphthyridine antibiotics for the manufacture of ophthalmic medicaments
IT8921490A0 (it) Procedimento e dispositivo per la fabbricazione di lattine mediante stiramento.
NO944075L (no) Fremgangsmåte for fremstilling av (S)-3-amino-1-substituert pyrrolidiner
NO175307C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 3,3'-ditiobis(propionsyrer)
NZ250300A (en) Asymmetric pyrrolidine derivatives
AU3709289A (en) Strontium salt
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
ATE172114T1 (de) Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält
NO881884L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
IL89401A0 (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
AU7379587A (en) Pharmaceutical formulation for the treatment of bacterial infections
AU6600190A (en) Therapeutic compositions; methods for treatment of hiv infections
AU2776389A (en) Beta-lactam antibiotics, processes for their preparation and their use as and in medicaments
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ES2131105T3 (es) Composiciones farmaceuticas de pentapeptidos y procedimientos de uso de las mismas.
AU4246189A (en) Medicament for the treatment of diseases caused by retroviruses

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0551848

Country of ref document: EP

REN Ceased due to non-payment of the annual fee